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Summary
A stable complex containing MLL1 and MOF has been
immunoaffinity purified from a human cell line that
stably expresses an epitope-tagged WDR5 subunit.
Stable interactions between MLL1 and MOF were con-
firmed by reciprocal immunoprecipitation, cosedi-
mentation, and cotransfection analyses, and interac-
tion sites were mapped to MLL1 C-terminal and MOF
zinc finger domains. The purified complex has a ro-
bust MLL1-mediated histone methyltransferase activ-
ity that can effect mono-, di-, and trimethylation of H3
K4 and a MOF-mediated histone acetyltransferase ac-
tivity that is specific for H4 K16. Importantly, both
activities are required for optimal transcription activa-
tion on a chromatin template in vitro and on an en-
dogenous MLL1 target gene, Hox a9, in vivo. These
results indicate an activator-based mechanism for
joint MLL1 and MOF recruitment and targeted methyl-
ation and acetylation and provide a molecular expla-
nation for the closely correlated distribution of H3 K4
methylation and H4 K16 acetylation on active genes.
Introduction
Many of the changes in chromatin structure induced by
transcription factors involve complex patterns of his-
tone modifications by enzymes such as histone acetyl-
transferases (HATs), histone methyltransferases (HMTs),
and kinases. Plasticity in transcription regulation and
coupled biological processes can be achieved by dy-
namic regulation of these histone modifications. The
varying format of chromatin modifications has led to
the hypothesis of a histone code, which suggests that
specific combinations of histone modifications dictate
specific transcriptional responses and cellular func-
tions (Strahl and Allis, 2000; Turner, 2002). Thus, it is
well established that transcriptionally active, euchro-
matic regions of the eukaryotic genomes are marked
by hyperacetylation of all four core histones, while
gene-poor, transcriptionally inactive heterochromatin
regions exhibit hypoacetylation (Vaquero et al., 2003).*Correspondence: roeder@mail.rockefeller.eduThe mechanistic basis for this was revealed by the dis-
covery that many transcriptional coactivators, such as
GCN5, p300/CBP, and MOF, proved to be histone ace-
tyltransferases (Carrozza et al., 2003). The effects of
histone acetylation are probably additive, given the lack
of site specificity for most HATs, with the H4 K16 acety-
lation catalyzed by MOF and its homologs being among
the exceptions (Carrozza et al., 2003; Dion et al., 2005).
Recent studies show that acetylation of H4 K16 is criti-
cal for chromatin decondensation (Corona et al., 2002)
and gene activation in the X chromosome of male Dro-
sophila (Smith et al., 2001). There also is accumulating
evidence that H4 K16 acetylation may be the founding
acetylation event on histone H4 (Smith et al., 2003;
Turner et al., 1992; Zhang et al., 2002).
Another histone modification strongly correlated with
transcription activation in a wide variety of eukaryotic
systems is H3 K4 methylation, especially the trimethy-
lated state (Santos-Rosa et al., 2002; Strahl et al.,
1999). Histone acetylation and H3 K4 methylation not
only are functionally correlated but also physically
linked, as demonstrated by the preferential localization
of trimethylated K4 residues in hyperacetylated H3
(Zhang et al., 2004). This strongly suggests that the en-
zymatic machineries that add these two marks may
function in a synergistic manner and, potentially, in-
teract with each other. This notion is supported by
demonstrations of physical interactions between Tri-
thorax (TRX) and CBP in Drosophila (Petruk et al., 2001)
and a transient interaction between MLL1 and CBP in
human cells (Ernst et al., 2001). The mechanism un-
derlying the synergism between histone acetylation
and H3 K4 methylation, and its functional implications,
remain to be elucidated.
Studies to date have described a number of mamma-
lian H3 K4 methyltransferases (Sims et al., 2003). MLL1,
of interest here, is the product of a protooncogene that
was first detected through chromosomal translocations
directly associated with aggressive lymphoid and my-
eloid acute leukemias, especially among infants (Hess,
2004). MLL1 has been implicated in Hox gene regula-
tion in early embryogenesis (Yu et al., 1995) and, more
recently, in the regulation of non-Hox genes such as
p27 (Kip1) and p18 (Ink4C) (Milne et al., 2005). Consis-
tent with its proposed role in transcriptional regulation
through modification of histones, chromatin immuno-
precipitation (ChIP) assays have shown accumulation
of MLL1 and corresponding H3 K4 methylation marks
on active target genes (Milne et al., 2002).
Among the known H3 K4 methyltransferases in mam-
mals, several (hSET1 MLL1, MLL2) have been found in
large complexes (Goo et al., 2003; Hughes et al., 2004;
Nakamura et al., 2002; Wysocka et al., 2003; Yokoyama
et al., 2004). While sharing some subunits (e.g., Ash2L
and WDR5), these complexes nevertheless contain
unique sets of proteins that suggest nonoverlapping
functions. In the case of MLL1, one study reported that
proteins from six different complexes associated with
MLL1 to form a single stable “supercomplex” (Naka-
mura et al., 2002). This complex was shown to have
Cell
874a K4 methyltransferase activity, but which was much n
iweaker than that of the recombinant MLL1 SET domain
and unable to use dimethyl H3 K4 as substrate. A sub- n
asequent study reported a much smaller MLL1-HCF
complex (six components in addition to MLL) with only n
kminimal overlap with the supercomplex but failed to
show any enzymatic activity of the complex (Yokoyama 2
et al., 2004).
To understand the function and mechanism of MLL1 i
tH3 K4 methyltransferase activity in transcriptional regu-
lation, we set out to purify an MLL1-containing complex e
ffor functional analysis in our chromatin-based in vitro
transcription assays (An et al., 2002). Given the pres- c
wence in the MLL1 supercomplex of an ortholog (WDR5)
to a component in the yeast SET1 complex (Krogan et o
tal., 2002), we developed an immunoaffinity purification
procedure based on expression in HeLa cells of an epi- c
2tope-tagged WDR5. Surprisingly, our studies have re-
sulted in isolation of a complex that contains not only (
tMLL1, WDR5, and other expected components, but
newly isolated components that include, most notably, n
wMOF, the MYST family HAT that specifically acetylates
H4 K16. This has led us to investigate and to document s
ia functional connection between the MLL HMT and the
MOF HAT activities both in vitro and in vivo. a
c
Results
p
qPurification and Characterization
tof an MLL1-WDR5 Complex
FAfter establishment of a HeLa cell line that stably ex-
ipresses Flag-tagged WDR5 (f-WDR5), derived nuclear
textracts were subjected to a three step purification
c(with MLL1 monitored by immunoblot) that involved
gconventional column chromatography on phosphocel-
alulose (P11) and SP Sepharose, followed by immunoaf-
pfinity purification on anti-Flag antibody (M2 agarose)
ibeads (Figure 1A). Although WDR5 is common to MLL1
c(Nakamura et al., 2002; Yokoyama et al., 2004), MLL2
M(Hughes et al., 2004), and hSET1/HCF (Wysocka et al.,
v2003) complexes, the first two steps efficiently separate
tMLL1 from hSET1 (mostly in the P11 BC300 and SP
MBC300 fractions) and MLL2 (mostly in P11 BC300 and
hSP BC300 fractions) and remove most of the unincor-
iporated f-WDR5 protein.
pMass spectrometric analysis of the purified f-WDR5-
acontaining MLL1 complex (designated MLL1-WDR5)
Mrevealed 29 proteins (listed alongside the zinc stained
cpolyacrylamide gel, Figure 1B), including the tagged
aWDR5, that were not present in the parallel mock-puri-
ofied preparation derived from a conventional HeLa
Mnuclear extract (data not shown). Five of these proteins
tare uncharacterized proteins in the database. Of the
aremaining 24 proteins, six were recently reported in the
pMLL1-HCF complex (Yokoyama et al., 2004). They are
the proteolytically derived MLLN and MLLC compo-
nents of MLL1, ASH2L, RbBP5, WDR5, and HCF1. They M
Tappear to represent the most tightly associated (“core”)
components of the MLL1 complex. With the notable ex- w
fceptions of RbBP5, WDR5, and some TAFs, most of the
proteins that were reported in the earlier MLL1 complex M
opreparation (Nakamura et al., 2002) were not detected
in our preparation by mass spectrometry or immu-oblot (data not shown). The most notable new proteins
n our MLL1-WDR5 preparation include TAF compo-
ents of TFIID, components of the E2F6 subcomplex,
nd MOF, a MYST family HAT. hSET1 and MLL2 were
ot detected by mass spectrometry. CBP, which is
nown to transiently interact with MLL1 (Ernst et al.,
001), also was not detected.
The mass spectrometry results were confirmed by
mmunoblot using available antibodies. In all cases
ested, proteins that were identified by mass spectrom-
try were confirmed (Figure 2A). Menin, which was
ound in both the MLL1-HCF complex and the MLL2
omplex, was detected by immunoblot even though it
as not detected by mass spectrometry. The human
rtholog (hMSL1) of Drosophila MSL1, which is known
o interact with Drosophila MOF in the evolutionarily
onserved dosage compensation complex (Smith et al.,
000), was not present in the MLL1-WDR5 complex
Figure 2B). Human TIP60, another MYST family HAT
hat shares sequence similarity with hMOF, also was
ot detected. Extremely low levels of hSET1 and MLL2
ere detected by immunoblot, but, consistent with the
eparation of most SET1 and MLL2 from MLL1 in the
on exchange steps (above), we were unable to detect
ny unique components (e.g., Sin3A) of the hSET1
omplex (Figure 2B).
Since the finding of hMOF in the MLL1-WDR5 com-
lex has important functional implications, our subse-
uent studies (described herein) were focused on in-
eractions of MOF with the MLL1-WDR5 complex.
unctional characterization of other identified proteins
s ongoing (see also below). In further confirmation of
he stable association of MOF with the MLL1-WDR5
omplex, MOF was found to cosediment on a sucrose
radient with other components (MLLC, Ash2L, RbBP5,
nd Ring2) of the three step purified MLL1-WDR5 com-
lex (Figure 2C). The apparent size of the MOF-contain-
ng MLL1-WDR5 complex is around 1.5 MDa. Recipro-
al immunoprecipitation of the three step purified
LL1-WDR5 complex with anti-MOF antibody also re-
ealed coimmunoprecipitation of MLL1 with other
ested components (f-WDR5, RbBP5, and Ring2) of the
LL1-WDR5 complex (Figure 2D). Importantly, TAFs,
SET1, and MLL2 were not detected in the anti-MOF
mmunoprecipitate. This suggests, for the M2 agarose
reparation, that the interactions between MLL1-WDR5
nd MOF are specific, that trace levels of hSET1 and
LL2 may reflect contaminating f-WDR5-containing
omplexes, and that TAFs (presumably as TFIID) are
ssociated with a distinct (MOF-deficient) subfraction
f WDR5-containing complex(es). The copurification of
OF with Flag-tagged RbBP5, another component of
he MLL1-WDR5 complex, provides further support for
stable association of MOF with the MLL1-WDR5 com-
lex (Figure 2E).
LL1 and MOF Interact Both In Vivo and In Vitro
o further substantiate intracellular MOF interactions
ith the MLL1-WDR5 complex, 293T cells were trans-
ected with vectors expressing HA-tagged MLL1 (HA-
LL1) and histidine-tagged MOF (His-MOF). Analysis
f derived cell lysates by Ni-NTA chromatography and
immunoblot revealed retention of MLL1-HA along with
MLL1 and MOF Interactions
875Figure 1. Purification and Mass Spectrometric Analysis of the MLL1-WDR5 Complex
(A) Scheme for three step purification of the MLL1-WDR5 complex.
(B) Zinc-stained 4%–20% gradient gel of proteins eluted from M2 agarose beads. Proteins identified by MALDI mass spectrometry are
indicated. Several proteins were recovered from more than one slice.His-MOF when both were coexpressed but not when
either was expressed alone (Figure 3A and data not
shown). Similar experiments with HA-MLL1 and His-
Ring2, another newly identified member of the MLL1-
WDR5 complex, and with HA-MOF and His-Ring2 re-
vealed MLL1-HA binding (Figure 3B) and MOF-HA
binding (Figure 3C) in conjunction with His-Ring2. Alto-
gether, these results provide further support for intra-
cellular interactions between MLL1, MOF, and Ring2
and their presence within a common complex.
Incubation of nuclear extract with GST-fused WDR5,
RbBP5, and MOF proteins also led to binding of endog-
enous MLL1 (data not shown), suggesting that MLL1
might serve as a scaffold for direct interaction of these
proteins and prompting an analysis of MLL1 domains
involved in the interactions. To this end, six MLL1 frag-
ments that cover both the MLLN region (M1–M4) and
the MLLC region (M5, M6) were generated by in vitro
transcription/translation and used in binding assays
(Figure 4C). MOF showed the strongest interaction with
the M5 fragment that contains the CID domain and a
weaker interaction with the M6 fragment that contains
the SET domain (Figure 4C). WDR5 and RbBP5 showed
similar strong and weak interactions with the M5 and
M6 fragments, respectively, but also showed significant
interactions with the M2 fragment that contains the
DNA methyltransferase homologous region (DNMT). A
further analysis with MLL1 M5 subfragments indicatedthat a region (residues 3100–3300) C-terminal to the
CID domain is required for mediating the interaction
with MOF (Figure 4D). These results extend a previous
study, involving different assays, which suggested that
WDR5 and RbBP5 interactions with MLL1 are depen-
dent on (but not necessarily restricted to) the SET do-
main (Yokoyama et al., 2004).
A similar scheme for mapping MLL1 interacting do-
mains in MOF employed GST fusion proteins contain-
ing full length MOF, MOF (1–235) (with deletion of HAT
domain), MOF (1–171) (with deletion of both the HAT
domain and the zinc finger). Both full-length MOF and
MOF (1–235), but not MOF (1–171) lacking the zinc fin-
ger, bound the M5 fragment, suggesting that the zinc
finger domain is required for the MLL1 interaction (Fig-
ure 4E). Similar results were obtained using purified
recombinant MLLC protein for the binding assay, indi-
cating that MOF directly interacts with MLLC in the
MLL1-WDR5 complex (Figure 4E).
The Purified MLL1-WDR5 Complex Has Both HMT
and HAT Activities
HMT and HAT activities of the three step purified MLL1-
WDR5 complex were assayed using both free histone
octamer and either native HeLa or recombinant nucleo-
somes as substrates. The purified MLL1-WDR5 com-
plex showed robust H3-specific HMT activities on all of
these substrates (Figure 5A). When assayed with a free
Cell
876Figure 2. Immunoblot Confirmation of Com-
ponents of the Purified MLL1-WDR5 Complex
(A) Immunoblot of selected proteins iden-
tified by mass spectrometry. In, input, SP
Sepharose BC500 fraction; FT, flowthrough;
E, elution. Antibodies used in this and other
(B–E) blots are indicated on the left.
(B) Immunoblot analysis of select compo-
nents previously identified in other com-
plexes as controls.
(C) Immunoblot analysis of 3-step purified
complex following fractionation by sucrose
gradient sedimentation. Sedimentation posi-
tions of molecular weight markers are indi-
cated at the top.
(D) Immunoprecipitation (IP) of the three step
purified complex by anti-MOF antibodies.
Mouse IgG was used for control IP.
(E) Immunoblot analysis of three step puri-
fied complex through Flag-RbBP5.recombinant histone octamer carrying the H3 K4Q mu- W
station, there was no detectable H3 methylation but, in-
stead, a low level of H2B methylation. In contrast, with a
Mthe more physiological (recombinant) nucleosome sub-
strate carrying the H3 K4Q mutation, all histone methyl- m
iation was lost (Figure 5A). Hence, the HMT activity is
specific for H3 lysine 4 (K4). c
wTo test the substrate specificity of the MLL1-WDR5
complex, H3 peptides that were either non-, mono-, di-, a
Dor trimethylated on K4 were used in HMT assays (Figure
5B). All except the trimethylated H3 K4 peptide served s
was substrates, although the dimethylated H3 K4 peptide
was a better substrate than unmodified and mono- W
cmethylated K4 (Figure 5B). This result differs from that
reported with the recombinant SET domain of MLL1, t
twhich failed to methylate dimethylated K4 peptides
(Milne et al., 2002; Nakamura et al., 2002). The failure u
of the trimethylated H3 K4 peptide to be further methyl-
ated, even though it has unmethylated K9, further de- H
Amonstrates the K4 specificity of the MLL1-WDR5
complex. BConsistent with the presence of MOF, the purified
MLL1-WDR5 complex also has a strong HAT activity.ith the free histone octamer substrate, the complex
hows a clear substrate preference for histone H4 but
lso acetylates H3 and H2A (Figure 5C). In contrast, the
LL1-WDR5 complex only acetylates H4 in nucleoso-
al substrates, thus showing a much greater specific-
ty with the more physiological substrate. The same
hange in acetylation pattern with different substrates
as previously observed for MOF in Drosophila (Akhtar
nd Becker, 2000; Smith et al., 2000). Since MOF in
rosophila was shown to specifically acetylate H4 ly-
ine 16 (Akhtar and Becker, 2000; Smith et al., 2000),
e also assayed the utilization of this site by the MLL1-
DR5 complex. Using recombinant nucleosomes re-
onstituted with H4 containing a K16 mutation, acetyla-
ion of H4 was dramatically decreased when compared
o H4 acetylation on a wild-type H4 nucleosome (Fig-
re 5C).
MT and HAT Activities of the MLL1-WDR5 Complex
ct Coordinately in Transcriptional Regulation
oth H3 K4 trimethylation and H4 K16 acetylation aremarks for active transcription (see Introduction). To test
the function of the HMT and HAT activities of the MLL1-
MLL1 and MOF Interactions
877Figure 3. Stable Intracellular Interactions of MLL1 and MOF
293T cells were transiently transfected with expression vectors encoding His-MOF and MLL1-HA (A), His-Ring2 and MLL1-HA (B), or His-
Ring2 and MOF-HA (C). For each analysis, proteins eluted from Ni-NTA were monitored by immunoblot with either anti-His or anti-HA antibody.bility, GST-p53, but not GST alone, was found to effi-dependent upon recruitment of cofactors that effect
Figure 4. Mapping of MLL1 and MOF Interaction Domains
(A) Schematic representation of MLL1 and derived fragments (see Supplemental Data).
(B) SDS-PAGE analysis of purified recombinant proteins used either for in vitro binding experiments or in the chromatin assembly reaction
(see Figure 6B).
(C) Interaction of in vitro-translated, 35S-methionine-labeled MLL1 fragments (indicated on the left) with GST-fusion proteins (indicated at
the top).
(D) Interactions of in vitro-translated, 35S-methionine-labeled M5-derived fragments with GST-MOF. Full-size translated proteins in the inputsWDR5 complex in transcription regulation, we turned
to our established in vitro transcription system using a
recombinant chromatin template assembled with the
Acf-1/ISWI/NAP1 system (Figure 6B; An et al., 2004). In
this system, activator-mediated transcription is stronglyare indicated by arrowheads.
(E) Interactions of MOF deletion mutants with MLL1 fragments. Indicate
translated, 35S-methionine-labeled M5 fragment or with a purified recombhistone modifications (An et al., 2004). Our previous
demonstration of p53-induced accumulation of H3 K4
methylation on an endogenous p53 target gene (An et
al., 2004) raised the possibility that this might be due
to MLL1 recruitment by p53. Consistent with this possi-d GST-MOF fusion proteins were incubated either with an in vitro
inant Flag-MLLC protein.
Cell
878Figure 5. The MLL1-WDR5 Complex Has
HMT and HAT Activities
(A) Methylation of H3 K4 by the MLL1-WDR5
complex on free histone octamers or on na-
tive or recombinant nucleosomes with wt or
mutated (K4Q) H3. Addition of purified
MLL1-WDR5 complex is indicated.
(B) Methylation by the MLL1-WDR5 complex
of H3 peptides with different levels of K4
premethylation.
(C) Acetylation of histones on free histone
octamers or nucleosomes with wt or mu-
tated (K16Q) H4. Addition of purified MLL1-
WDR5 complex is indicated.ciently bind MLL1, MOF, and other components of the M
AMLL1-WDR5 complex from HeLa nuclear extracts (Fig-
ure 6A). This interaction allowed us to use p53 as the G
aactivator for our in vitro transcription assay. When as-
sayed according to the scheme in Figure 6B, p53- H
gdependent transcription was significantly enhanced by
the MLL1-WDR5 complex when added with S-adenosyl a
emethionine (SAM; allowing methylation) or acetyl-CoA
(allowing acetylation). This activation is a direct result b
Mof HMT and HAT activities of the MLL1-WDR5 complex
since adding the MLL1-WDR5 complex without cofac- e
ators or adding cofactors without the MLL1-WDR5 com-
plex had no effect (Figure 6C). Higher levels of activity p
othat were at least equal to the sum of the individual
SAM and acetyl-CoA activities were observed when e
HSAM and acetyl-CoA were added together with the
MLL1-WDR5 complex, indicating a moderate coopera- p
wtivity between MLL1 and MOF (Figure 6C, lane 4). This
transcription activation is activator dependent, since f
tthe transcription activity is greatly reduced in the ab-
sence of p53 (Figure 6C, lane 5). The results of several a
pindependent transcription experiments are quantified
and summarized in Figure 6D. Further mechanistic i
(analysis showed p53-dependent H3 methylation and
H4 acetylation of the chromatin template by the MLL1- w
cMOF-WDR5 complex (Figure 6E). These results are
consistent with the results of the p53 interaction and l
ttranscriptional activation studies and indicate that co-
activation by MLL1 and MOF involves targeted (p53- (
dependent) histone acetylation and methylation.LL1 Targets Both H3 K4 Methylation and H4 K16
cetylation Activities to the Hoxa9 Locus
iven the physical and functional interactions of MLL1
nd MOF, we next examined H4 K16 acetylation and
3 K4 trimethylation on well-established MLL1 target
enes in vivo. Three cell lines have been used: Mll(+/+)
nd Mll(−/−) fibroblast lines established from day 10.5
mbryos and an Mll(−/−) + MLL1 line established by sta-
ly transfecting Mll(−/−) cells with a human Flag-tagged
LL1 expression construct (Milne et al., 2002). Hoxa9
xpression measured by quantitative RT-PCR showed
greater than 5-fold difference in Mll(+/+) cells com-
ared with Mll(−/−) cells. However, ectopic expression
f MLL1 in Mll(−/−) cells restored much of the Hoxa9
xpression (Figure 7A). To detect MLL1 binding at the
oxa9 locus, ChIP assays for four Hoxa9 regions were
erformed (Figure 7B). These regions were located
200–300 bp upstream of the first exon (1), within the
irst exon (2,3) and within second exon that contains
he homeodomain (4) of Hoxa9 (Figure 7C). Using an
ntibody against MLLC in the CHIP assay, and as ex-
ected, MLL1 binding was detected in all four regions
n wild-type Mll(+/+) cells and in Mll(−/−) + MLL1 cells
Figure 7D). As a control, binding at the Gapdh locus
as at a background level similar to that seen in Mll(−/−)
ells. Consistent with the binding of MLL1 to the Hoxa9
ocus, changes of H3 K4 dimethylation and trimethyla-
ion tightly correlated with MLL1 binding to this locus
regions 1-4). Fold differences between the di- and tri-methylation levels of H3 K4 in Mll(+/+) and Mll(−/−) +
MLL1 and MOF Interactions
879Figure 6. The HMT and HAT Activities of the MLL1-MOF Complex Modify Histones in an Activator-Dependent Manner and Act Coordinately
to Effect p53-Dependent Transcription on Chromatin
(A) Binding of the MLL1-WDR5 complex (from nuclear extract) to GST-p53. Bound proteins (indicated at left) were analyzed by immunoblot.
(B) Schematic of in vitro transcription assay using recombinant chromatin templates (An and Roeder, 2004).
(C) Chromatin-templated transcription assays with p53, purified MLL1-WDR5 complex, acetyl-CoA, and SAM addition as indicated and
according to the scheme in (B).
(D) Quantitation by phosphoimager of data as in (C) (lanes 1–5) is shown. y axis indicates transcription levels relative to lane 5 (p53-indepen-
dent basal activity). Average and standard deviations (error bars) from three autoradiographic analyses are indicated at the bottom.
(E) Histone modification assays on chromatin templates with p53, purified MLL1-WDR5 complex, acetyl-CoA, and SAM additions as indicated.MLL1 cells compared with that in Mll(−/−) cells are
shown in Figures 7E and 7F. As a control, no change in
di- or trimethylation was seen at the Gapdh locus,
which does not have bound MLL1.
We next examined H4 acetylation using antibodies
against specific lysine residues, namely K5, K8, K12,
and K16, across the Hoxa9 locus in the three cell lines.
These four acetylation sites showed very different re-
sponses in relation to bound MLL1. There was no
change in K5 acetylation and only small increases in K8and K12 acetylation at the Hoxa9 locus in Mll(+/+) cells
and in Mll(−/−) + MLL1 cells when compared with
Mll(−/−) cells (Figures 7G, 7H, and 7I). In contrast, the
K16 acetylation level increased dramatically across the
Hoxa9 locus in both Mll(+/+) and Mll(−/−) + MLL1 cells
(Figure 7J). Comparing the changes in H3 K4 methyla-
tion and in H4 K16 acetylation within the Hoxa9 locus,
a close correlation of these two marks was also ob-
served. There was gradual increase of H3 K4 methyla-
tion from regions 1 to 4, and a similar pattern was de-
Cell
880Figure 7. Specific Increase of H4 K16 Acety-
lation upon MLL1 Binding at the Hoxa9 Pro-
moter
(A) Reduced Hoxa9 expression in Mll(−/−)
cells and restoration by ectopic MLL1.
Hoxa9 expression in wt cells (dark gray) is
arbitrarily set as 100%. Standard deviations
in this and other experiments (D–J) are indi-
cated by error bars.
(B) Legend for (D)–(H). Dark gray, Mll(+/+)
cells; white, Mll(−/−) cells; light gray, Mll(−/−) +
ectopic MLL1-expressing cells.
(C) Four probe sets in the Hoxa9 locus used
for real-time PCR quantification of ChIP.
Black bars indicate CpG-rich regions of the
locus; arrows indicate two different tran-
scription start sites (Fujimoto et al., 1998);
putative TATA boxes are shown (Nakamura
et al., 2002), and the first and second exons
are shown as gray boxes. The homeodomain
(HD) in exon 2 is indicated by crosshatching.
(D–J) ChIP experiments in Mll(+/+), Mll(−/−),
and Mll(−/−) + MLL1 cells using the indicated
antibodies. ChIP was quantified using the
Taqman primer/probe sets indicated in (C).
Signals in Mll(−/−) cells were set to 1, and sig-
nals in Mll(+/+) and Mll(−/−) + MLL1 cells were
expressed as fold differences relative to
Mll(−/−) cells. (D) MLLC, (E) H3 di-MeK4, (F) H3
tri-MeK4, (G) H4 AcK5, (H) H4 AcK12, (I) H4
AcK8, (J) H4 AcK16.tected for H4 K16 acetylation. Since, in all cases, we t
dscored the fold difference in histone modifications at
the Hoxa9 locus in Mll(+/+) and Mll(−/−) + MLL1 cells to d
(that in Mll(−/−) cells, the changes in K4 methylation and
H4 K16 acetylation reported here are MLL1 dependent. M
dNo MLL1-dependent changes in H3 K4 methylation or
H4 K16 acetylation were seen at the Gapdh locus, t
lwhich is not regulated by MLL1, suggesting that
changes observed at the Hoxa9 locus require MLL1
abinding. Thus, these analyses have established a clear
correlation between H3 K4 methylation and H4 K16 a
bacetylation at the Hoxa9 locus and, most significantly,
a strong dependence of the H4 K16 acetylation on the f
spresence of MLL1.
t
rMOF Is Required for the Expression of HOXA9
sThe in vivo function of MOF on the well-established
lMLL1 target gene HOXA9 was further explored in HeLa
scells. MOF expression was effectively eliminated by
csiRNA techniques (Figure 8A). As revealed by immu-
8noblot using acetylated H3 as an internal control, MOF
MsiRNA resulted in a significant reduction of the global
aH4 K16 acetylation level (w30%) relative to that ob-
sserved with control siRNA-treated cells. This indicates
Mthat MOF is the major histone acetyltransferase for this
site in vivo. Quantitative real time RT-PCR analysis fur- vher showed that HOXA9 expression was significantly
ownregulated (>50% decrease) in the MOF knock-
own cells compared to control siRNA-treated cells
Figure 8B). The expression of GAPDH, which is not an
LL1 target, was less affected (inconsistent small re-
uctions were observed in some cases) by MOF siRNA
reatment. In all cases, HOXA9 and GAPDH expression
evels were normalized to total input RNA.
To detect H4 K16 acetylation and H3 K4 methylation
t the HOXA9 locus, ChIP assays were directed toward
HOXA9 TATA-containing region (1) locatedw200–300
p upstream of the first exon and a region (3) within the
irst exon (Figure 7C). MOF knockdown resulted in a
ignificant reduction of H4 K16 acetylation both around
he TATA region (w50% decrease) and in the coding
egion (w70% decrease). Consistent with the expres-
ion results, the K16 acetylation level on GAPDH was
ess (and inconsistently) affected by MOF siRNA. No
ignificant changes in trimethylation at the HOXA9 lo-
us were observed in MOF siRNA-treated cells (Figure
D). This indicates that whereas H4 K16 acetylation by
OF is dependent upon MLL1 (Figure 7), H3 K4 methyl-
tion by MLL1 can occur independently of MOF. Con-
idering that MOF stably associates with MLL1, that
LL1 and MOF coordinately activate transcription in
itro, and that K16 acetylation at the HOXA9 locus is
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Decrease of Histone H4 Lysine 16 Acetyla-
tion and HOXA9 Expression
(A) MOF siRNAs, M1 and M2, decrease MOF
protein and global H4 K16 acetylation levels.
Acetylated H3 was used as internal loading
control.
(B) MOF siRNA treatment reduces HOXA9
gene expression. Expression levels of
HOXA9 and GAPDH in MOF siRNA-treated
cells (M1 and M2) are normalized to levels in
control cells (C). Standard deviations in (B)–
(C) are indicated by error bars.
(C) Histone H4 K16 acetylation at HOXA9
and GAPDH loci in MOF (M1 and M2) and
control (C) siRNA-treated cells. The K16
acetylation level in MOF siRNA-treated cells
is normalized to the level in control cells (C),
which is arbitrarily set as 1.
(D) Histone H3 K4 methylation at the HOXA9
locus in MOF (M1) and control (C) siRNA-
treated cells. H3 K4 methylation in control
cells (C) is arbitrarily set as 1.MLL1 dependent, it is highly probable that downregula-
tion of HOXA9 by MOF siRNA treatment is specific
and direct.
Discussion
Studies to date indicate that the chromatin modifica-
tions associated with gene activation are diverse and
involve the action of combinations of histone modifying
enzymes/coactivators (Fischle et al., 2003; Turner,
2002). In studies directed toward the function of human
MLL1 in transcription activation through H3 K4 methyl-
ation, we have identified a stable complex (MLL1-
WDR5) containing both MLL1 and the MYST family
histone acetyltransferase MOF. The relevance of the
demonstrated ability of this complex to effect both H3
K4 methylation (mono-, di-, tri-) and H4 K16 acetylation,
to interact with a transcriptional activator, and to stimu-
late activator-dependent transcription through the resi-
dent HMT and HAT activities in vitro is underscored by
our concomitant demonstration of MLL1-dependent H3
K4 methylation and H4 K16 acetylation events on a
known MLL1 target gene. Altogether, these results indi-
cate a coordinate function of MLL1 and MOF, through
a physical association, in gene activation events. Along
with complementary studies (Wysocka et. al., 2005 [this
issue of Cell]) indicating direct interactions of WDR5,
an MLL1-interacting component of the MLL1-MOF
complex, with methylated H3 K4 residues, these results
also lead to a model for both the establishment and
spreading of K4 methylation, perhaps in conjunction
with H4 K16 acetylation, in transcriptionally active chro-
matin.
MLL1 and MOF Can Form a Stable Complex In Vivo
The MLL1-WDR5 complex purified on the basis of an
intrinsic epitope-tagged subunit (WDR5) represents a
unique subpopulation of cellular MLL1 complexes with
novel components (notably MOF; see Table S1 in the
Supplemental Data available with this article online).This idea is supported by our observation of two MLL1-
containing peaks following the fractionation of nuclear
extract by gel filtration (data not shown) and by previ-
ous indications of heterogeneity in the MLL1-HCF prep-
aration (Yokoyama et al., 2004).
That MOF is a bona fide component of an MLL1-con-
taining complex is indicated by (1) copurification
through ion-exchange chromatography and affinity pu-
rification steps (involving epitope-tagged WDR5 or
RbBP5), (2) cosedimentation on sucrose gradients of
MOF with MLL1 and other core components (WDR5,
Ash2L, RbBP5) of the purified MLL1-WDR5 complex,
(3) coimmunoprecipitation of MLL1 and select compo-
nents (including Ash2L, RbBP5, Ring2, and WDR5) of
the MLL1-WDR5 preparation using anti-MOF antibody,
(4) coimmunoprecipitation of MLL1, MOF, and Ring2
following pairwise expression in transfected cells, and
(5) direct in vitro interactions between MLL1 and MOF,
through mapped subdomains. The possibility that MOF
might also be associated with contaminating hSET1
and MLL2 complexes, which also contain WDR5, is
ruled out by the failure of anti-MOF antibodies to coim-
munoprecipitate the residual amounts of hSET1 or
MLL2 in the MLL1-WDR5 preparation and by MOF
coimmunoprecipitation with f-RbBP5 (which is not a
component of the hSET1 complex). This is consistent
with the greater abundance of MOF (detected by mass
spectrometry) relative to hSET1 or MLL2 (not detected
by mass spectrometry) in the MLL1-WDR5 preparation.
Although well-studied in Drosophila, very little is
known about MOF in mammalian cells. The Drosophila
ortholog (dMOF) of human MOF is important for dosage
compensation of the male X chromosome and acts
through an H4 K16 acetylation mechanism that effects
a 2-fold activation of transcription (Smith et al., 2000).
In Drosophila, dMOF function in dosage compensation
depends on its integration into a complex with male-
specific MSL1, MSL2, and other components (Morales
et al., 2004). It has been suggested that a similar dos-
age compensation complex also exists in mammals
Cell
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tsince mammals use a totally different mechanism for
dosage compensation. The presence in the MLL1- r
tWDR5 complex of MOF suggests that, in mammals,
MOF probably plays an alternative role in transcription w
regulation that is independent of the dosage compen-
sation system. H
C
TThe MLL1-WDR5 Complex Is Enzymatically Active
Although lysine residues may be mono-, di-, or trimeth- s
aylated in vivo, the trimethyl H3 K4 is preferentially and
strongly associated with the transcribed regions of l
Hactive genes from yeast to higher eukaryotes (Krogan
et al., 2002; Ng et al., 2003; Santos-Rosa et al., 2002; o
tSchneider et al., 2004). In yeast, SET1 is the only H3 K4
methyltransferase and can methylate H3 K4 to all three p
olevels. In contrast, higher eukaryotes contain several
H3 K4 methyltransferases with various specificities, a
csuggesting a more complex picture for the regulation
and function of H3 K4 methylation in higher eukaryotes t
t(Sims et al., 2003).
The purified MLL1-WDR5 complex shows a robust T
tH3 K4 methyltransferase activity on H3 peptide, free
histone octamer, and nucleosomal substrates. Impor- c
itantly, like SET1 in yeast, the MLL1-WDR5 complex is
active with non-, mono-, and dimethylated substrates t
Sand, in particular, efficiently converts dimethylated H3
K4 residues (the preferred substrate) to trimethylated t
eresidues. This result is consistent with the view that
MLL1 is directly involved in transcription activation of p
pHox genes as a consequence of the enhanced levels of
H3 K4 trimethylation associated with MLL1 binding to o
fHox gene promoters in vivo. This result contrasts with
the reported inability of the MLL1 supercomplex (weak W
tHMT activity) or the MLL1 SET domain (much stronger
HMT activity) to effect H3 K4 trimethylation. Thus, and o
iconsistent with its distinct composition relative to that
of the first reported MLL1 complex (Nakamura et al., M
c2002), the MLL1-WDR5 complex described here is
more likely to be the functionally active MLL1 complex. K
iSince a recombinant MLLC fragment (180 kDa) shows
extremely weak activity compared with the MLL1- t
oWDR5 complex (data not shown), it appears that MLL1,
like yeast SET1, must be associated with other compo- h
enents for full activity. With respect to the MLL1-associ-
ated HAT activity of MOF, Drosophila MOF has an un- i
iusually narrow substrate specificity and only acetylates
histone H4 K16 on a nucleosomal template (Akhtar and o
Becker, 2000; Smith et al., 2000). Moreover, faithful and
efficient acetylation of nucleosomal histone H4 by MOF a
cis observed only upon interaction with MSL1 and MSL3
(Morales et al., 2004). MOF in the MLL1-WDR5 complex t
tshows a similar preference for H4 K16 on nucleosomes.
In fact, the observed reduction of global H4 K16 acety- H
alation in MOF knockdown cells suggests that MOF is
one of the major histone acetyltransferases involved in m
sH4 K16 acetylation and may play important roles in
functions other than dosage compensation. c
mAnalysis of the MOF and MLL1 interaction domains
has further shown that MLL1, via a C-terminal domain, (
tinteracts with the zinc finger of MOF. Given that an in-
teraction of dMOF with MSL1 through its zinc finger is t
essential for correct targeting of MOF to the male Xhromosome (Morales et al., 2004), analogous interac-
ions of hMOF with MLL1 through the same zinc finger
egion may imply new functions for MOF, possibly by
argeting different sets of genes through its interaction
ith MLL1-WDR5.
MT and HAT Activities of the MLL1-WDR5 Complex
an Act Coordinately in Transcriptional Regulation
he use of a chromatin-templated assay in which tran-
cription is dependent upon a transcriptional activator
nd interacting chromatin modifying cofactors has al-
owed us to document in vitro functions of the MLL1
MT and MOF HAT activities. Thus, in the absence of
ther factors (p300, CARM1, PRMT1) previously shown
o serve as coactivators in this assay (An et al., 2004),
53-mediated transcription is dependent upon addition
f the MLL1-MOF-WDR5 complex and either SAM or
cetyl-CoA. The dependence on these cofactors indi-
ates that the coactivator functions can be attributed
o the histone methyltransferase and histone acetyl-
ransferase activities of MLL1 and MOF, respectively.
he inability of p53 to enhance transcription upon addi-
ion of SAM and acetyl-CoA without the MLL1-WDR5
omplex indicates that the observed activation by p53
s not due to endogenous MLL1 or MOF. Reciprocally,
he lack of an effect of the MLL1-WDR5 complex (with
AM and acetyl-CoA) in the absence of p53 indicates
hat transcription activation does not result from gen-
ral (nontargeted) modifications of the chromatin tem-
late. This is further indicated by our demonstration of
53-dependent (targeted) methylation and acetylation
f chromatin template histones by MLL1 and MOF. The
act that histone modifications by the MLL1-MOF-
DR5 complex are p53 dependent and correlate with
ranscriptional activation indicates a direct involvement
f MLL1 and MOF in p53-dependent transcription. This
s consistent with our demonstrated interaction of the
LL1-WDR5 complex with p53, as well as prior indi-
ations of p53-induced accumulation of methylated H3
4 on a p53 target gene (An et al., 2004). The possible
nvolvement of the MLL1-WDR5 complex in transcrip-
ion initiation is consistent with the reported enrichment
f di- and trimethylated H3 K4 at active promoters in
igher eukaryotes (Santos-Rosa et al., 2002; Schneider
t al., 2004) and is further supported by studies indicat-
ng enhanced transcription of a reporter with Gal4 bind-
ng sites following expression (and artificial recruitment)
f a Gal4-WDR5 fusion protein (Wysocka et al., 2005).
The coordinate action of MLL1 HMT and MOF HAT
ctivities in the in vitro assays is in agreement with the
lose correlation between H3 K4 methylation and his-
one acetylation marks in vivo but describes coopera-
ion that is site specific and involves only H3 K4 and
4 K16. In contrast to other acetylated residues on H4,
cetylated K16 is known to play a pivotal role in deter-
ining the potential of coding DNA for expression or
ilencing. Thus, (1) only the H4 K16 mutation has spe-
ific transcription consequences independent of the
utational state of the other lysines (Dion et al., 2005),
2) in yeast, H4 K16 is the only residue whose acetyla-
ion can, on its own, prevent silencing of the mating
ype genes (Johnson et al., 1990; Megee et al., 1990),and (3) MOF can activate transcription in yeast when
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gesting that a rather local acetylation may lead to a
significant stimulation of transcription (Akhtar and
Becker, 2000). The potentially cooperative in vivo func-
tions between H3 K4 methylation and H4 K16 acetyla-
tion have clearly been demonstrated by the downregu-
lation of a well-established MLL1 target gene, Hoxa9,
in MOF siRNA-treated cells and by a specific increase
in H4 K16 acetylation, which is dependent on MLL1 and
closely correlated with the MLL1-dependent increase
in H3 K4 methylation, in the same locus. Our hypothesis
of coordinate MLL1 and MOF function is further sup-
ported by our demonstration that MOF, like other (e.g.,
RbBP5) components of MLL1-WDR5 complex, can
bind to methylated H3 K4 through WDR5, arguing for
the joint recruitment of HMT and HAT activities to the
same targets (Figure S2).
Model for Transcription Activation
Our demonstration of transcriptional activation through
the HMT (MLL1) and HAT (MOF) activities in the MLL1-
WDR5 complex, direct interaction of the complex with
a DNA binding transcriptional activator, and binding of
a resident subunit (WDR5) to methylated H3 K4 (Wy-
socka et al., 2005) lead to a model for both the estab-
lishment and spreading of an active chromatin struc-
ture. The model invokes activator binding to DNA
regulatory elements, activator-mediated recruitment of
the MLL1-WDR5 complex, consequent methylation and
acetylation, and either the recruitment of additional
MLL1-WDR5 complexes or internucleosomal transfer
of primary MLL1-WDR5 complexes through binding of
the WDR5 subunit to methylated H3 K4 or through
binding of the MLL1 bromodomain to acetylated H4
K16 residue. This model is related, in part, to that pro-
posed for propagation of heterochromatin by H3 K9
methylation and subsequent HP1 binding (Lachner et
al., 2001).
Previously established H3 K4 methylation marks can
also be recognized by other effectors, such as CHD1 in
the SAGA complex (Pray-Grant et al., 2005) and com-
ponents in ATP-dependent chromatin remodeling com-
plexes (Beisel et al., 2002; Santos-Rosa et al., 2003).
Similarly, acetylation marks can also be recognized by
various bromodomains (Hassan et al., 2001) that are
common structural features of many histone acetyl-
transferases (Turner, 2002). Recruitment of other HAT
complexes and ATP-remodeling complexes by mole-
cules that directly or indirectly interact with methyl- or
acetylmarks may further facilitate the spreading of
“open chromatin” and enable RNA polymerase to effi-
ciently move through the chromatin template for
active transcription.
Experimental Procedures
Cell Lines
Mll(+/+), Mll(−/−), and Mll(−/−) + MLL cell lines have been described
previously (Milne et al., 2002). The f-WDR5 and f-RbBP5 cell lines
were made by transfecting HeLa S3 cells with either an f-WDR5-
pIRESneo vector or an f-RbBP5-pIRESneo vector.
Fractionation of Nuclear Extracts
Nuclear extracts were obtained from f-WDR5 or f-RbBP5 cells by a
modified Dignam procedure (Dignam et al., 1983) and fractionatedaccording to the scheme in Figure 1A. For sucrose gradient sedi-
mentation, 500 l purified MLL1-WDR5 complex (from 50 ml
nuclear extract) was loaded onto an 11 ml 10% to 40% (w/v) su-
crose gradient. After centrifugation for 16 hr at 23,000 rpm (SW41
rotor), 0.5 ml fractions were collected.
Immunoaffinity Purification of the MLL1-WDR5 Complex
and Mass Spectrometry
The SP Sepharose BC500 fraction was incubated with M2 agarose
in BC300, 0.05%NP40 at 4°C for 4 hr and extensively washed with
BC500, 0.05% NP40. The complex was eluted with 0.25 mg/ml Flag
peptide in BC100. The eluted MLL1-WDR5 complex was resolved
by SDS-PAGE and visualized by zinc staining. The entire gel lane
was sliced into 2 mm bands and proteins were subjected to MALDI
mass spectrometry (Krutchinsky et al., 2000; Krutchinsky et al.,
2001). Proteins were identified by XProteo (Chao Zhang; http://
www.xproteo.com). Common background proteins (i.e., keratins,
tubulins, ribosomal proteins) were excluded from the list of in-
teracting proteins. We also note that WDR5-Flag was identified in
multiple bands, which may be due to breakdown and/or over-
loading.
Antibodies
Anti-MLLC antibody was generated using the previously described
epitope (Hsieh et al., 2003). Other antibodies were obtained com-
mercially as follows: anti-MLL-N, hSET1, MLL2, menin, RbBP5, and
Ash2 (Bethyl Laboratory); anti-TIP60 (Santa Cruz); mouse IgG, M2,
and M2 agarose (Sigma); anti-His (Qiagen); anti-HA (Roche); anti-
H3 dimethyl K4 and trimethyl K4 (Abcam); anti-H4 acetyl K5, acetyl
K8, acetyl K12, and acetyl K16 (Upstate Biotechnology). Anti-MOF
and anti-MSL1 antibodies will be described elsewhere (E.R.S., C.
Cayrou, R. Huang, W.S. Lane, J. Cote, and J.C. Lucchesi, unpub-
lished data).
Plasmids and Expression Vectors
Bacterial vectors for core histone expression and purification were
as described (Luger et al., 1999). Mutations (H3 K4 and H4 K16)
were introduced by PCR-based site-directed mutagenesis. Flag-
tagged p53 and the DNA template for transcription were as de-
scribed (An et al., 2004). GST and GST-tagged WDR5, RbBP5, MOF
full length, MOF (1–171), and MOF (1–235) proteins were expressed
in bacteria from the pGEX4T-1 vector (Amersham). A Flag-tagged
MLLC cDNA was inserted into pVL1392 baculovirus vector (Bac-
vector 3000, Novagen). For transfection assays, cDNAs encoding
tagged MLL1, MOF, and Ring2 proteins were inserted into the CMV-
driven expression vector pIRESneo (Clontech). Manufacturer’s pro-
tocols for the TNT Quick coupled transcription/translation system
(Promega) were used for in vitro translation. Information for in vitro
translation templates is in the Supplemental Data.
GST Pull-Down Assay
For GST pull-down assays, 4 g GST-tagged protein and 200 l
HeLa NE, 10 l of the TNT translation reaction or 2 g purified
recombinant MLLC were used in each binding assay. Reactions
were carried out at 4°C for 4 hr and beads were washed three times
with BC200.
Histone Modification Assays
Unmodified, mono-, di-, and trimethylated H3 K4 peptides were
from Upstate Biotechnology. HeLa nucleosomes were purified as
described (Owen-Hughes et al., 1999). Recombinant nucleosomes
were prepared by salt dialysis using 5S array DNA from G5ML
(Kundu et al., 2000) and recombinant histone octamers were recon-
stituted as described (Luger et al., 1999). For each HMT or HAT
assay, 5 g peptide, 2 g HeLa nucleosomes, or 2 g recombinant
nucleosomes were used. Reactions were carried out at 30°C for 1
hr in the presence of [3H]-SAM (S-adenosyl-L-[methyl-3H] methio-
nine) or [3H]-acetyl-CoA.
Chromatin Modifications and Transcription Assays
Chromatin assembly and histone modification reactions were car-
ried out with coactivators essentially as described (An and Roeder,
Cell
8842004). Transcription assays included 40 ng p53 and about 100 ng t
fpurified MLL1-WDR5 for each reaction.
D
Chromatin Immunoprecipitation (ChIP) and Q-PCR Reactions t
Chromatin immunoprecipitations were performed using the Chro- a
matin Immunoprecipitation Assay Kit (Upstate, Lake Placid, New
E
York) and protocols recommended by the manufacturer. Real-time
(
PCR quantitation of ChIP was performed in triplicate using Taqman
t
probes and an ABI Prism 7700 (Applied Biosystems) and both the
Frelative quantification and percent input methods as outlined in
cMilne et al. (2002). Real-time PCR quantitations of Hoxa9 and
Gapdh expression in MOF siRNA experiments were normalized F
against input total RNA. m
t
hRNA Interference
HeLa cells were transfected with siRNA duplexes (200 pmol; Dhar- G
macon) using Oligofectamine (Invitrogen) according to the manu- K
facturer’s instructions. One additional round of transfection was t
performed under identical conditions 48 hr after the initial transfec- t
tion. Cells were harvested 48 hr after the second transfection. The 2
sequences for MOF small interfering RNAs (siRNAs) used in the
Hassays are available upon request.
t
n
HSupplemental Data
lSupplemental Data include two figures, one table, and Supplemen-
tal Experimental Procedures and can be found with this article on- H
line at http://www.cell.com/cgi/content/full/121/6/873/DC1/. m
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